CD44, a therapeutic target for metastasising tumours
V Orian-Rousseau - European journal of cancer, 2010 - Elsevier
Members of the CD44 family of transmembrane glycoproteins, in particular CD44v6
isoforms, were shown to be metastatic determinants of rat pancreatic tumour cells back in …
isoforms, were shown to be metastatic determinants of rat pancreatic tumour cells back in …
Adhesion molecules—The lifelines of multiple myeloma cells
BZ Katz - Seminars in Cancer Biology, 2010 - Elsevier
Multiple myeloma is an incurable hematological malignancy of terminally differentiated
immunoglobulin-producing plasma cells. As a common presentation of the disease, the …
immunoglobulin-producing plasma cells. As a common presentation of the disease, the …
Co‐culture with mesenchymal stromal cells increases proliferation and maintenance of haematopoietic progenitor cells
T Walenda, S Bork, P Horn, F Wein… - Journal of cellular …, 2010 - Wiley Online Library
Mesenchymal stromal cells (MSC) have been suggested to provide a suitable cellular
environment for in vitro expansion of haematopoietic stem and progenitor cells (HPC) from …
environment for in vitro expansion of haematopoietic stem and progenitor cells (HPC) from …
CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells
Homing of chronic lymphocytic leukemia (CLL) cells to sites favoring growth, a critical step in
disease progression, is principally coordinated by the CXCL12/CXCR4 axis. A cohort of 62 …
disease progression, is principally coordinated by the CXCL12/CXCR4 axis. A cohort of 62 …
The effects of telomerase inhibition on prostate tumor‐initiating cells
CO Marian, WE Wright, JW Shay - International journal of …, 2010 - Wiley Online Library
Prostate cancer is the most common malignancy in men, and patients with metastatic
disease have poor outcome even with the most advanced therapeutic approaches. Most …
disease have poor outcome even with the most advanced therapeutic approaches. Most …
Strategies to enhance umbilical cord blood stem cell engraftment in adult patients
C Delaney, MZ Ratajczak… - Expert review of …, 2010 - Taylor & Francis
Umbilical cord blood (UCB) has been used successfully as a source of hematopoietic stem
cells (HSCs) for allogeneic transplantation in children and adults in the treatment of …
cells (HSCs) for allogeneic transplantation in children and adults in the treatment of …
[HTML][HTML] N-cadherin is expressed on human hematopoietic progenitor cells and mediates interaction with human mesenchymal stromal cells
F Wein, L Pietsch, R Saffrich, P Wuchter, T Walenda… - Stem cell …, 2010 - Elsevier
Specific cell–cell junctions between hematopoietic stem cells (HSC) and their niche have
been shown to regulate stem cell function. N-cadherin was suggested to play a central role …
been shown to regulate stem cell function. N-cadherin was suggested to play a central role …
SDF-1 provides morphological and functional protection against renal ischaemia/reperfusion injury
G Stokman, I Stroo, N Claessen… - Nephrology dialysis …, 2010 - academic.oup.com
Background. The chemokine stromal cell-derived factor-1 (SDF-1) is thought to be involved
in mediating tissue repair by promoting migration of bone marrow stem or progenitor cells to …
in mediating tissue repair by promoting migration of bone marrow stem or progenitor cells to …
Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?
S Tavor, I Petit - Seminars in cancer biology, 2010 - Elsevier
Poor prognosis of acute leukemia with current treatments is mainly due to the relapse of the
disease following chemotherapy. In the last decade, an emerging concept has proposed that …
disease following chemotherapy. In the last decade, an emerging concept has proposed that …
Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology
B Cate, M De Bruyn, Y Wei, E Bremer… - Current drug …, 2010 - ingentaconnect.com
Despite recent advances, treatment of leukemia is often not curative. New insights indicate
that this may be attributable to a small population of therapy-resistant malignant cells with …
that this may be attributable to a small population of therapy-resistant malignant cells with …